Accuracy of the new rapid test for monitoring adalimumab levels
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.23/1323 |
Resumo: | The loss of response to adalimumab (ADL) has been related to low serum concentrations at trough. Currently, most methods commercially available for the quantification of ADL are enzyme-linked immunosorbent assay (ELISA) based, with a turnaround time of approximately 8 h, delaying the target dosage adjustment to the subsequent infusion. In this study, we aimed to evaluate the performance of the newly available rapid-test ADL quantification assay by comparing it with three established ELISA methods, using spiked samples and a set of clinical samples. |
id |
RCAP_34d1ea1fdb751df3e003c44acc2fdd07 |
---|---|
oai_identifier_str |
oai:repositorio.hospitaldebraga.pt:10400.23/1323 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Accuracy of the new rapid test for monitoring adalimumab levelsAdalimumabThe loss of response to adalimumab (ADL) has been related to low serum concentrations at trough. Currently, most methods commercially available for the quantification of ADL are enzyme-linked immunosorbent assay (ELISA) based, with a turnaround time of approximately 8 h, delaying the target dosage adjustment to the subsequent infusion. In this study, we aimed to evaluate the performance of the newly available rapid-test ADL quantification assay by comparing it with three established ELISA methods, using spiked samples and a set of clinical samples.Repositório Científico do Hospital de BragaRocha, CAfonso, JLago, PArroja, BVieira, AIDias, CCMagro, F2019-05-16T12:44:42Z2019-01-01T00:00:00Z2019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.23/1323engTherap Adv Gastroenterol. 2019 Feb 27;12:1756284819828238.10.1177/1756284819828238info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-21T09:03:14Zoai:repositorio.hospitaldebraga.pt:10400.23/1323Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:55:51.149702Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Accuracy of the new rapid test for monitoring adalimumab levels |
title |
Accuracy of the new rapid test for monitoring adalimumab levels |
spellingShingle |
Accuracy of the new rapid test for monitoring adalimumab levels Rocha, C Adalimumab |
title_short |
Accuracy of the new rapid test for monitoring adalimumab levels |
title_full |
Accuracy of the new rapid test for monitoring adalimumab levels |
title_fullStr |
Accuracy of the new rapid test for monitoring adalimumab levels |
title_full_unstemmed |
Accuracy of the new rapid test for monitoring adalimumab levels |
title_sort |
Accuracy of the new rapid test for monitoring adalimumab levels |
author |
Rocha, C |
author_facet |
Rocha, C Afonso, J Lago, P Arroja, B Vieira, AI Dias, CC Magro, F |
author_role |
author |
author2 |
Afonso, J Lago, P Arroja, B Vieira, AI Dias, CC Magro, F |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório Científico do Hospital de Braga |
dc.contributor.author.fl_str_mv |
Rocha, C Afonso, J Lago, P Arroja, B Vieira, AI Dias, CC Magro, F |
dc.subject.por.fl_str_mv |
Adalimumab |
topic |
Adalimumab |
description |
The loss of response to adalimumab (ADL) has been related to low serum concentrations at trough. Currently, most methods commercially available for the quantification of ADL are enzyme-linked immunosorbent assay (ELISA) based, with a turnaround time of approximately 8 h, delaying the target dosage adjustment to the subsequent infusion. In this study, we aimed to evaluate the performance of the newly available rapid-test ADL quantification assay by comparing it with three established ELISA methods, using spiked samples and a set of clinical samples. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-05-16T12:44:42Z 2019-01-01T00:00:00Z 2019-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.23/1323 |
url |
http://hdl.handle.net/10400.23/1323 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Therap Adv Gastroenterol. 2019 Feb 27;12:1756284819828238. 10.1177/1756284819828238 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130427017920512 |